ClinicalMetric / Countries / Hungary / advanced malignancies
← 🇭🇺 Hungary Trials
🇭🇺 Hungary Country × Condition

advanced malignancies Clinical Trials in Hungary

Active clinical trials for advanced malignancies with research sites in Hungary. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇭🇺 Hungary

Active Trials in Hungary (1)

NCT04752826 Phase 1, Phase 2
Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Enrollment
176 pts
Country
🇭🇺 Hungary
BioInvent International AB
View Trial →

Frequently Asked Questions

How many advanced malignancies clinical trials are active in Hungary?
There are currently 1 active clinical trials for advanced malignancies with sites in Hungary, of which 1 are actively recruiting patients.
How can I join a advanced malignancies clinical trial in Hungary?
To join a advanced malignancies clinical trial in Hungary, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Hungary directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are advanced malignancies trials in Hungary?
Active advanced malignancies trials in Hungary span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Hungary Trials → Global advanced malignancies Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology